Long intergenic non-protein coding RNA 2327 (LINC02327)

Long intergenic non-protein coding RNA 2327 (LINC02327) is a human long intergenic non-coding RNA (lincRNA) gene that gives rise to a transcript longer than 200 nucleotides and does not overlap or encode a protein-coding gene[1]. LincRNAs generally function as regulators of transcription, epigenetic state, chromatin structure, and nuclear architecture in a sequence- and context-dependent manner, often exhibiting tissue- and developmental-stage-specific expression[1][3]. While several lincRNAs are functionally characterized in cancer and other diseases, the specific function, disease role, or druggability of LINC02327 has not been established in the current literature. LINC02327 remains a genomically annotated lincRNA, potentially implicated in fine-tuning of gene expression, but it is not considered a conventional therapeutic target, and no drugs, biomarkers, or safety data are specifically published for this molecule[1][5]. If more information becomes available on experimentally validated roles, drug interactions, or disease associations for LINC02327, these entries should be updated accordingly.

Other names

CTD-2384A14.1LINC02327LOC107984685

None. No mechanistically described drug actions specific to LINC02327; lincRNAs are generally not directly drug targets.